Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characterization of the Melanoma-Specific Immune Response (Melanoma)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00368615
Recruitment Status : Recruiting
First Posted : August 25, 2006
Last Update Posted : May 27, 2020
Sponsor:
Information provided by (Responsible Party):
University of California, Davis

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2021
Estimated Study Completion Date : April 2022